Trial Outcomes & Findings for Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration? (NCT NCT02774148)
NCT ID: NCT02774148
Last Updated: 2023-09-28
Results Overview
Pain scores will be compared between the two groups.
TERMINATED
PHASE4
1 participants
6 days
2023-09-28
Participant Flow
Participant milestones
| Measure |
PO Acetaminophen
1,000mg Acetaminophen po every 8 hours until discharge.
PO Acetaminophen: The patient will receive 1,000mg po Acetaminophen every 8 hours.
|
IV Acetaminophen
1,000mg Acetaminophen IV every 8 hours until the patient has received 3 doses post-operatively. Then 1,000mg Acetaminophen po every 8 hours until discharge.
IV Acetaminophen: The patient will receive 1,00mg IV Acetaminophen every 8 hours until 3 doses have been received post-operatively.
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration?
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 6 daysPopulation: No analyses complete due to early termination.
Pain scores will be compared between the two groups.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 daysPopulation: No analyses complete due to early termination.
The amount of opioid pain medication a patient receives will be recorded and the Morphine equivalents will be determined by an opioid dose calculator. The morphine equivalents will be compared between the two groups.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 daysPopulation: No analyses complete due to early termination.
The timing of the first day of ambulation will be compared between the two groups.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 daysPopulation: No analyses complete due to early termination.
The distance ambulated will be compared between the two groups.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 2 weeksPopulation: No analyses complete due to early termination.
Length of hospital stay will be compared between the two groups.
Outcome measures
Outcome data not reported
Adverse Events
PO Acetaminophen
IV Acetaminophen
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place